UWCCC Molecular Tumor Board Registry

Description

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

Conditions

Hematologic Neoplasms, Solid Neoplasm

Talk to us

Study Overview

On this page

Study Details

Study overview

This study seeks to evaluate the clinical utility of the Precision Medicine Molecular Tumor Board, and to track patient outcomes.

UWCCC Precision Medicine Molecular Tumor Board Registry

UWCCC Molecular Tumor Board Registry

Condition
Hematologic Neoplasms
Intervention / Treatment

-

Contacts and Locations

Madison

University of Wisconsin Carbone Cancer Center, Madison, Wisconsin, United States, 53792

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinically suspected or histologically confirmed solid or hematological malignancy
  • * Undergoing genetic testing of tumor
  • * Ability to understand written informed consent document
  • * Willingness to sign written informed consent document
  • * Pediatric patients (age\<18 years) will be excluded due to a lack of expertise on the molecular tumor committee

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Wisconsin, Madison,

Mark Burkard, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

2027-03